IGM Biosciences Inc at Barclays Global Healthcare Conference Transcript
Good afternoon. Welcome to Barclays Global Healthcare Conference. My name is Peter Lawson. I'm one of the biotech analysts at Barclays. It gives me great pleasure to introduce Misbah Tahir, CFO; and Angus Sinclair, VP of Immuno-Oncology from IGM Biosciences.
Questions & Answers
And maybe just as kind of a kickoff question, Misbah, perhaps you could kind of just give us a general high-level introduction on the pipeline and therapeutic focus and burn rate at the moment.
Yes, happy to do so. And Peter, first, thank you for having us at this conference and giving us the opportunity to speak. Really excited to be here.
IGM, in a nutshell, is the global leader in the development of engineered IgM antibodies. We believe what we're doing is really different from anyone else out there in the field, and we're
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |